指南与共识肺结节与肺癌

肺癌筛查:CHEST指南与专家小组报告

Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.
指南 / 共识 · Chest · 2021-07-13

该指南基于系统文献综述(新增75项研究)更新低剂量CT肺癌筛查的证据,针对12个关键问题形成7条分级推荐和9条未分级共识声明。证据提示低剂量CT筛查的获益与危害可达到有利平衡,但受筛查对象选择、影像质量与判读、筛查发现管理及戒烟干预效果影响。

要点

  • 低剂量CT肺癌筛查的获益与危害可达到有利平衡。
  • 筛查对象选择、影像质量与判读、筛查发现管理影响平衡。
  • 戒烟干预效果可影响筛查的净获益。

核心结论

  • 证据提示低剂量CT肺癌筛查的获益与危害可达到有利平衡。
  • 筛查对象选择、影像质量与判读、筛查发现管理及戒烟干预效果可影响该平衡。

研究设计与样本

  • 指南制定机构为CHEST,采用PICO格式确定关键问题。
  • 系统检索MEDLINE via PubMed、Embase和Cochrane Library,自上一版指南发布起每季度检索。
  • 采用GRADE方法评估证据质量,证据充足时进行Meta分析。
  • 系统文献综述新增识别75项研究,回应12个关键问题。
  • 形成7条分级推荐和9条未分级共识声明。

主要发现

  • 系统文献综述新增识别75项研究以回应12个关键问题。
  • 形成7条分级推荐和9条未分级共识声明。

关键数值与推荐

  • 7条分级推荐和9条未分级共识声明(具体条款未在摘要中列出)。

临床怎么用

  • 临床应关注筛查对象选择、影像质量与判读、筛查发现管理及戒烟干预效果,以优化低剂量CT筛查的获益-危害平衡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Low-dose chest CT screening for lung cancer has become a standard of care in the United States, in large part because of the results of the National Lung Screening Trial (NLST). Additional evidence supporting the net benefit of low-dose chest CT screening for lung cancer, and increased experience in minimizing the potential harms, has accumulated since the prior iteration of these guidelines. Here, we update the evidence base for the benefit, harms, and implementation of low-dose chest CT screening. We use the updated evidence base to provide recommendations where the evidence allows, and statements based on experience and expert consensus where it does not. METHODS: Approved panelists reviewed previously developed key questions using the Population, Intervention, Comparator, Outcome format to address the benefit and harms of low-dose CT screening, and key areas of program implementation. A systematic literature review was conducted using MEDLINE via PubMed, Embase, and the Cochrane Library on a quarterly basis since the time of the previous guideline publication. Reference lists from relevant retrievals were searched, and additional papers were added. Retrieved references were reviewed for relevance by two panel members. The quality of the evidence was assessed for each critical or important outcome of interest using the Grading of Recommendations, Assessment, Development, and Evaluation approach. Meta-analyses were performed when enough evidence was available. Important clinical questions were addressed based on the evidence developed from the systematic literature review. Graded recommendations and ungraded statements were drafted, voted on, and revised until consensus was reached. RESULTS: The systematic literature review identified 75 additional studies that informed the response to the 12 key questions that were developed. Additional clinical questions were addressed resulting in seven graded recommendations and nine ungraded consensus statements. CONCLUSIONS: Evidence suggests that low-dose CT screening for lung cancer can result in a favorable balance of benefit and harms. The selection of screen-eligible individuals, the quality of imaging and image interpretation, the management of screen-detected findings, and the effectiveness of smoking cessation interventions can impact this balance.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Mazzone PJ, Silvestri GA, Souter LH, et al. Screening for Lung Cancer: CHEST Guideline and Expert Panel Report. Chest. 2021. PMID: 34270968. doi:10.1016/j.chest.2021.06.063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。